About the International Myeloma Foundation
Founded in 1990, the International Myeloma Foundation (IMF) is the world’s leading organization dedicated to multiple myeloma.
Our Mission:
The IMF is steadfast in our mission: Accelerating the prevention and cure of myeloma and improving the quality of life for patients and families.
The people of the IMF — our Board of Directors, our management, and our staff — are here to help you. We invite you to learn more about our team.
The IMF has assembled a global dream team of renowned myeloma experts. We leverage the Scientific Advisory Board’s collective knowledge and experience to identify new areas of research, collaborate on international research initiatives, and strengthen the scientific rigor of ongoing projects.
We partner with organizations all over the world. Together, we promote awareness of multiple myeloma and encourage measures to prevent and combat the disease.
The International Myeloma Foundation is dedicated to finding a cure for those living with multiple myeloma. We have a range of initiatives to make this happen.
Because "Knowledge Is Power," the IMF brings educational seminars and workshops to communities near you, and provides a library of publications on multiple myeloma care.
Since our inception in 1990, the IMF has supported and met in-person with thousands of patients globally. At our annual Support Group Leaders Summit, the reach is to more than 6,000 patients and caregivers.
The IMF’s Advocacy team has educated and empowered thousands of individuals who make a positive impact each year on issues critical to the myeloma community in the U.S. and worldwide.
The patient experience is the focus of everything we do. Every interaction is an opportunity to establish a personal connection built on care and compassion, which is the basis for continued support.
As a team, we value honesty and transparency while creating a culture of mutual respect. We foster a myeloma community built on sincerity, authenticity, and kindness.
We value accountability, personal responsibility, and a steadfast commitment to excellence. We respect the legacy and reputation of our organization while seeking new solutions and advancement to improve outcomes, quality of life, and access to the best available resources for everyone impacted by myeloma.
We recognize each team member’s skills and talents through collaboration and cooperation. Our programs aim to celebrate and support the diversity of our patients and their communities.
In 2023, the IMF unveiled the organization’s Global Strategy Plan for 2023-2027. This plan is “a set of strategies” that were written during the first nine months of 2023 and were based on input from the patients we serve, global key opinion leaders, industry partners, and other collaborators. The strategy focuses on purposeful targeted innovation in the service of those who need us most.
